Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The objective of the trial is to compare disease-free survival between adjuvant
capecitabine/cisplatin alone vs capecitabine/cisplatin with radiotherapy (chemoradiation) in
curatively resected gastric cancer patients.